139 related articles for article (PubMed ID: 35073298)
1. Impact of Cold Therapy on Paclitaxel-Induced Peripheral Neuropathy and Quality of Life in Patients With Breast Cancer.
Jue MY; Shah D; Stiles A; Nisar T
Clin J Oncol Nurs; 2022 Feb; 26(1):93-99. PubMed ID: 35073298
[TBL] [Abstract][Full Text] [Related]
2. Cryotherapy for the prevention of weekly paclitaxel-induced peripheral adverse events in breast cancer patients.
Shigematsu H; Hirata T; Nishina M; Yasui D; Ozaki S
Support Care Cancer; 2020 Oct; 28(10):5005-5011. PubMed ID: 32036471
[TBL] [Abstract][Full Text] [Related]
3. Cold therapy to prevent paclitaxel-induced peripheral neuropathy.
Griffiths C; Kwon N; Beaumont JL; Paice JA
Support Care Cancer; 2018 Oct; 26(10):3461-3469. PubMed ID: 29681015
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial using surgical gloves to prevent chemotherapy-induced peripheral neuropathy by paclitaxel in breast cancer patients (AIUR trial).
Kang YJ; Yoon CI; Yang YJ; Baek JM; Kim YS; Jeon YW; Rhu J; Yi JP; Kim D; Oh SJ
BMC Cancer; 2023 Jun; 23(1):570. PubMed ID: 37340369
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy of cryotherapy and compression therapy for preventing nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: A prospective self-controlled trial.
Kanbayashi Y; Sakaguchi K; Ishikawa T; Ouchi Y; Nakatsukasa K; Tabuchi Y; Kanehisa F; Hiramatsu M; Takagi R; Yokota I; Katoh N; Taguchi T
Breast; 2020 Feb; 49():219-224. PubMed ID: 31901783
[TBL] [Abstract][Full Text] [Related]
6. Randomized controlled trial of cryotherapy to prevent paclitaxel-induced peripheral neuropathy (RU221511I); an ACCRU trial.
Ruddy KJ; Le-Rademacher J; Lacouture ME; Wilkinson M; Onitilo AA; Vander Woude AC; Grosse-Perdekamp MT; Dockter T; Tan AD; Beutler A; Loprinzi CL
Breast; 2019 Dec; 48():89-97. PubMed ID: 31590108
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Siriraj, in-house-developed, frozen gloves for cold therapy reduction of chemotherapy-induced peripheral neuropathy in gynecological cancer patients: randomized controlled trial.
Chitkumarn P; Rahong T; Achariyapota V
Support Care Cancer; 2022 Jun; 30(6):4835-4843. PubMed ID: 35147758
[TBL] [Abstract][Full Text] [Related]
8. Cryotherapy for prevention of chemotherapy induced peripheral neuropathy in breast cancer.
Tandon M; Yacur M; Brenin C; Dillon P
Crit Rev Oncol Hematol; 2024 Feb; 194():104244. PubMed ID: 38135017
[TBL] [Abstract][Full Text] [Related]
9. Persistent weekly paclitaxel-induced peripheral neuropathy in early breast cancer patients enrolled in a randomized trial of cryotherapy.
Shigematsu H; Kimura Y; Itagaki T; Yasui D
Medicine (Baltimore); 2023 Apr; 102(16):e33580. PubMed ID: 37083796
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the effect of N-acetylcysteine on the prevention and amelioration of paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled study.
Khalefa HG; Shawki MA; Aboelhassan R; El Wakeel LM
Breast Cancer Res Treat; 2020 Aug; 183(1):117-125. PubMed ID: 32601973
[TBL] [Abstract][Full Text] [Related]
11. Effect of cryotherapy on paclitaxel-induced peripheral neuropathy of the hand in female breast cancer patients: A prospective self-controlled study.
Yang TT; Pai HC; Chen CY
Int J Nurs Pract; 2023 Aug; 29(4):e13094. PubMed ID: 35971279
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D deficiency increases severity of paclitaxel-induced peripheral neuropathy.
Jennaro TS; Fang F; Kidwell KM; Smith EML; Vangipuram K; Burness ML; Griggs JJ; Van Poznak C; Hayes DF; Henry NL; Hertz DL
Breast Cancer Res Treat; 2020 Apr; 180(3):707-714. PubMed ID: 32166478
[TBL] [Abstract][Full Text] [Related]
13. Effect of Exercise on Taxane Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer: A Randomized Controlled Trial.
Bland KA; Kirkham AA; Bovard J; Shenkier T; Zucker D; McKenzie DC; Davis MK; Gelmon KA; Campbell KL
Clin Breast Cancer; 2019 Dec; 19(6):411-422. PubMed ID: 31601479
[TBL] [Abstract][Full Text] [Related]
14. Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial.
Shimozuma K; Ohashi Y; Takeuchi A; Aranishi T; Morita S; Kuroi K; Ohsumi S; Makino H; Katsumata N; Kuranami M; Suemasu K; Watanabe T; Hausheer FH
Support Care Cancer; 2012 Dec; 20(12):3355-64. PubMed ID: 22584733
[TBL] [Abstract][Full Text] [Related]
15. Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer.
Song SJ; Min J; Suh SY; Jung SH; Hahn HJ; Im SA; Lee JY
Support Care Cancer; 2017 Jul; 25(7):2241-2248. PubMed ID: 28204996
[TBL] [Abstract][Full Text] [Related]
16. Long-term peripheral neuropathy symptoms in breast cancer survivors.
Mustafa Ali M; Moeller M; Rybicki L; Moore HCF
Breast Cancer Res Treat; 2017 Nov; 166(2):519-526. PubMed ID: 28791499
[TBL] [Abstract][Full Text] [Related]
17. Effect of cilostazol on preventing paclitaxel-induced neuropathy in patients with breast cancer: A randomized controlled trial.
Haroun EA; Mansour NO; Eltantawy A; Shams MEE
Pharmacotherapy; 2023 Sep; 43(9):872-882. PubMed ID: 37199288
[TBL] [Abstract][Full Text] [Related]
18. The effect of salt-water bath in the management of treatment-related peripheral neuropathy in cancer patients receiving taxane and platinum-based treatment.
Emine KE; Gulbeyaz C
Explore (NY); 2022; 18(3):347-356. PubMed ID: 34340926
[TBL] [Abstract][Full Text] [Related]
19. A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients.
Bao T; Seidman AD; Piulson L; Vertosick E; Chen X; Vickers AJ; Blinder VS; Zhi WI; Li Q; Vahdat LT; Dickler MN; Robson ME; Mao JJ
Eur J Cancer; 2018 Sep; 101():12-19. PubMed ID: 30007894
[TBL] [Abstract][Full Text] [Related]
20. Weekly Paclitaxel-Induced Neurotoxicity in Breast Cancer: Outcomes and Dose Response.
Timmins HC; Li T; Trinh T; Kiernan MC; Harrison M; Boyle F; Friedlander M; Goldstein D; Park SB
Oncologist; 2021 May; 26(5):366-374. PubMed ID: 33523545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
